Daily Washington Insider
  • Business
  • World
  • Science
  • Investing

Daily Washington Insider

  • Business
  • World
  • Science
  • Investing
Science

England’s first artificial cornea transplant hailed a success

by admin June 4, 2024
June 4, 2024
England’s first artificial cornea transplant hailed a success

A 91-year-old man has become the first person in England to be fitted with a ground-breaking artificial cornea.

Cecil ‘John’ Farley, 91, said his sight was now improving thanks to the procedure, which he underwent after 15 years of suffering from problems with his eyes.

The cornea is the clear outer layer at the front of the eyeball – and is described by the NHS as the “window to the eye”.

A person can suffer from vision problems and pain if the thin transparent covering is damaged by disease or injury – with those affected often left facing a long wait for a human transplant.

However, it is hoped that the artificial device, called EndoArt, will slash waiting times, ease pressure on the NHS and eliminate the risk of the human body rejecting corneas received from an organ donor.

Mr Farley, from Chobham in Surrey, said he was overjoyed by the transplant – in his right eye – because it meant he could continue to see his 83-year-old wife Elizabeth.

He said: “I can still see my wife after 63 years of marriage, we can just carry on as normal and live life as fully as we can.

“It makes your life fuller when your eyes work properly – you don’t realise how debilitating it is until it happens to you.”

Before the surgery, Mr Farley had no vision in his right eye – but his sight has slowly been improving ever since the procedure in February.

He said: “It has made a great difference to my sight. It was very blurred and I couldn’t distinguish a face.

“Now I can see better with it, the brighter the light the better. It’s coming along slowly – they said it could take up to a year.”

The artificial cornea has been compared to a contact lens. The device, which replaces the inner part of the cornea, is surgically attached to the eye by a single stitch and is put in place with a gas bubble.

Only 200 people worldwide, including Mr Farley, have been fitted with an EndoArt so far, but there are hopes it can be more widely rolled out.

Organic cornea transplants usually come from deceased donors. A total of 4,719 were donated to the NHS in 2022/23, according to the latest available figures.

Consultant ophthalmologist Thomas Poole, from Frimley Health NHS Foundation Trust in Surrey, which carried out the procedure, described the artificial cornea as a “great advancement”.

He said there had been fears that Mr Farley was “kind of getting to [his] last hope” after a previous human transplant failed.

Mr Poole said: “I had a very frank discussion with him before and I said: ‘Look, your graft has failed, you’re back on the waiting list. Because your other eye sees quite well, you’re not a high priority on the waiting list and you could be waiting for another year’.

“He’s in his 90s now and said ‘I just can’t wait that long. Is there anything else?’ And so this sprung to mind.

“I had just read a publication on very good reports from this artificial graft and it was that that made me think actually, maybe we could use this for John.”

Mr Poole and his colleague Hanbin Lee have now successfully given four patients artificial corneas in the last two months and the initial results have shown an improvement in vision.

He added: “Looking forward to the future, I think this may end up replacing human corneas for certain types of corneal graft patients.

“In maybe 10 or 20 years’ time – this may become the norm where we don’t need a human cornea, and we can just take one out of the box.”

Mr Farley, a former flooring company owner, said that once his sight is restored he hopes to do practical tasks like repairing a watch.

However, for now, he is content “pottering about”.

This post appeared first on sky.com

0
FacebookTwitterGoogle +Pinterest
previous post
Brightstar Resources
next post
New vaccine treatment increases chances of survival for patients with deadly skin cancer, study finds

You may also like

Kabosu dies: Shiba inu which inspired the ‘doge’...

May 25, 2024

Elon Musk set to interview Donald Trump –...

August 13, 2024

Tesla Cybertruck buyers reporting delivery delays over ‘windscreen...

June 18, 2024

Hyper-realistic humanoid robots could be used in psychotherapy

June 12, 2024

Weight-loss jab Wegovy may help people stop smoking,...

July 30, 2024

AI to watch every spoonful you eat and...

June 5, 2024

Temu faces legal challenge over ‘manipulative practices’

May 16, 2024

Apple reports biggest drop in iPhone sales since...

May 3, 2024

Pembrokeshire army barracks to house deep space radar...

August 8, 2024

Complex life on Earth began around 1.5 billion...

July 29, 2024

    Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Popular

    • 1

      Tartana Drilling to Verify Upgrading of 45,000 Tonne Copper Resource

    • 2

      Magic mushrooms effective for treating depression – study

    • 3

      Lancaster Resources Welcomes Three Highly Experienced Industry Experts to Its Advisory Board

    • 4

      Hong Kong plans to install thousands of surveillance cameras. Critics say it’s more proof the city is moving closer to China

    • 5

      UN experts urge Thailand not to deport dozens of Uyghurs to China where they face ‘real risk of torture’

    Categories

    • Business (1,129)
    • Investing (2,670)
    • Science (605)
    • World (3,241)
    Footer Logo

    Disclaimer: dailywashingtoninsider.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2024 dailywashingtoninsider.com | All Rights Reserved